- Preparing for Flooding During Hurricane Season
- How You Can Help Prevent Suicide During the COVID-19 Pandemic
- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
- Conspiracy Theories Are Helping Fuel Rejection of Masks, Vaccines
- U.S. Coronavirus Cases Top 7 Million
- Health Highlights: Sept. 25, 2020
- After COVID-19 Exposure, When Can Young Athletes Resume Play?
- Kids Who Need Steroids Face Risk of Diabetes, Other Ills
Clinical Trials Update: Feb. 10, 2010
(HealthDayNews) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Type 2 Diabetes
This is a 26-week study to evaluate the effectiveness of an investigational drug in people with type 2 diabetes.
The research site is in Escondido, Calif.
More Information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Major Depressive Disorder
If you are aged 18 to 65 and have symptoms of depression, you may qualify for this study of an investigational drug.
The research site is in New York City.
More Information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
—–
Rheumatoid Arthritis
If your rheumatoid arthritis symptoms persist despite treatment, you may qualify for this study of an investigational medication.
The research site is in Duncansville, Penn.
More Information
Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
